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ABSTRACT 
Apparent diffusion coefficient (ADC) of cerebral water, as measured by diffusion MRI, rapidly 
decreases in ischaemia highlighting a lesion in acute stroke patients. The MRI T2 relaxation 
time changes in ischaemic brain such that T2 in ADC lesions may be informative of the extent 
of tissue damage, potentially aiding in stratification for treatment. We have developed a novel 
user-unbiased method of determining the changes in T2 in ADC lesions as a function of clinical 
symptom duration based on voxel-wise referencing to a contralateral brain volume. The 
spherical reference method calculates the most probable pre-ischaemic T2 on a voxel-wise 
basis, making use of features of the contralateral hemisphere presumed to be largely 
unaffected. We studied whether T2 changes in the two main cerebral tissue types, i.e. in grey 
matter (GM) and white matter (WM), would differ in stroke.  
Thirty-eight acute stroke patients were accrued within 9 hours of symptom onset and scanned 
at 3T for 3D T1-weighted, multi b-value diffusion and multi-echo spin echo MRI for tissue type 
segmentation, quantitative ADC and absolute T2 images, respectively. T2 changes measured 
by the spherical reference method were 1.94 ± 0.61, 1.50 ± 0.52 and 1.40 ± 0.54 ms/hour in 
the whole, GM and WM lesions, respectively. Thus, T2 time courses were comparable between 
GM and WM independent of brain tissue type involved. We demonstrate that T2 changes in 
ADC-delineated lesions can be quantified in the clinical setting in a user unbiased manner and 
that T2 change correlated with symptom onset time, opening the possibility of using the 
approach as a tool to assess severity of tissue damage in the clinical setting.  
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1. INTRODUCTION 
 
Ischaemia resulting in catastrophic energy failure followed by anoxic depolarization, causes a 
dramatic drop in the apparent diffusion coefficient (ADC) of water, which enables detection of 
ischaemic stroke in the brain by diffusion MRI (Moseley et al., 1990; Busza et al., 1992). In 
acute strokes, brain parenchyma with an ADC lowered by more than 20% is commonly 
considered as the ischaemic core (Hossmann, 1994; Burgess and Kidwell, 2011). MRI 
relaxation time changes in the ischaemic core are very small in magnitude in the early 
moments of ischaemia (Kauppinen, 2014). However, recent evidence points to a potential 
value of relaxation times in stroke onset time evaluation (Siemonsen et al., 2009; Jokivarsi et 
al., 2010; McGarry et al., 2016). Combined diffusion and relaxometric MRI would therefore 
bear an impact on stroke patient stratification, keeping in mind that up to 30% of acute patients 
present with unknown onset (Thomalla et al., 2011). While diffusion MRI contrast is 
conspicuous to the naked eye in acute stroke, T2-weighted or quantitative T2 MRI signals 
become brighter only many hours after symptom onset which is often outside the time window 
for treatment with thrombolysis. The so-called diffusion/FLAIR MRI mismatch, which exploits 
qualitative signal intensities of diffusion and T2-weighted images, has been successfully used 
to stratify stroke patients within the thrombolysis time window of 4.5 hours (Thomalla et al., 
2011; Thomalla et al., 2018). Similarly to T2-weighted signal, the quantitative T2 relaxation time 
image also shows weak contrast in early hours of stroke, thus requiring special means to 
measure the effects of ischaemia on quantitative T2. The mirror reference approach uses an 
anatomically homologous contralateral brain volume as a non-ischaemic reference to 
measure a difference in quantitative T2 in the ADC-defined ischaemic core (Siemonsen et al., 
2009). Using the mirror reference procedure, it has been shown that quantitative T2 at 1.5T 
increases by ~10% by 4 hours after symptom onset in brain parenchyma, providing a means 
to estimate lesion age within the thrombolysis time window (Siemonsen et al., 2009). The 
mirror reference approach requires precise positioning of non-ischaemic reference into intact 
brain parenchyma (Norton et al., 2017), which is not often straightforward in aged human 
brain. 
 
The brain parenchyma consists of two main tissue types, grey matter (GM) and white matter 
(WM), having greatly different cell and biochemical compositions, receptor distributions, 
electrophysiology, metabolic rates of oxygen and glucose, and haemodynamics. Because of 
these fundamental neurobiological differences, these two brain tissue types show inherently 
different T1 and T2 relaxation time values resulting in contrast in respective MR images. ADC 
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values are quantitively comparable in GM and WM and, consequently, orientation-unbiased 
ADC images show little contrast between these tissue types. Whether the above-mentioned 
quantitative MRI parameters have different time courses in GM and WM following stroke 
remains to be studied. Diffusion MRI of rat brain shows a dramatic drop in ADC when cerebral 
blood flow (CBF) reduces by approximately 80% (Hossmann, 1994; Grohn et al., 2000). 
Recent studies on human stroke patients using either perfusion MRI (Bristow et al., 2005) or 
perfusion computerized tomography (CT) (Chen et al., 2017) in combination with diffusion MRI 
reported that CBF thresholds for the ischaemic core in GM is higher than in WM. In addition 
to different haemodynamic thresholds to ischaemia, anoxic depolarizations show different 
kinetics in the two tissue types. Anoxic depolarisation in ischaemic feline GM attains the lowest 
values in 5 – 10 minutes, whereas in WM it reaches the minimum by ~30 – 40 minutes (Kumura 
et al., 1999). Anoxic depolarization is associated with a shift of water from the extracellular 
into the intracellular space, i.e. cytotoxic oedema, which is one of key factors leading to a 
decrease both in ADC (Sotak, 2002) and T2 relaxation rate (Knight et al., 2015). In global 
ischaemia in cats, ADC in the thalamus (representing GM) decreases with a time constant 
that is three-fold faster than in the internal capsule (representing WM) (Pierpaoli et al., 1996) 
in accordance with the anoxic depolarization data (Kumura et al., 1999). In the light of these 
observations it would be of clinical interest to determine stroke onset time-dependent 
quantitative T2 changes in GM and WM to deduce the best use of this MRI indicator for brain 
tissue state assessment in stroke patient management. 
 
In the present paper we present a novel method to measure T2 relaxation time change as a 
function of stroke onset time in mixed tissue type lesions, as well as in GM and WM separately, 
in the ADC-defined ischaemic core. The approach is called the spherical reference method 
which, with the aid of T2-weighted MR images, is based on a voxel-level search for 
contralateral, non-ischaemic, reference sphere voxels that are optimally matched to the 
parenchyma that is affected by stroke. We have used both the spherical and mirror reference 
approaches (Siemonsen et al., 2009) to quantify effects of acute stroke on quantitative T2 in 
the ADC-defined stroke lesion.  
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2. Methods 
2.1. Human data acquisition and processing 
The study received ethical approval to accrue acute stroke patients from South West Frenchay 
Research Ethics Committee for participants in Bristol (ref 13/SW/0256), Scotland A REC for 
participants in Glasgow (ref 16/SS/0223) and UK National Research Ethics Service 
committees (ref: 12/SC/0292 and 13/SC/0362) for participants in Oxford. Informed consent 
was received either from participants or their legal representative prior to enrolment to the 
study. Stroke patients were recruited if they presented in the emergency department with 
witnessed symptom onset so that MRI scans could be completed within 9 hours of onset. 
Details of the human acute stroke cohort is given in Table 1. The project was carried out in 
accordance with the Declaration of Helsinki.  
 
All MRI scans on acute stroke patients were acquired using 3T scanners: Philips Achieva 
(Bristol); Siemens Magnetom Prisma (Glasgow); Siemens Magnetom Verio (Oxford). At each 
of the three sites, a 32-channel head-coil was used. The details of the T1, diffusion, and T2 
pulse sequences and acquisition parameters are given in Table 2. 
 
Quantitative T2 maps were obtained by fitting a mono-exponential decay on a voxel-wise 
basis. All T2-weighted images of the echo-series were summed to produce a sum-over-echoes 
image, which was subject to bias-field correction (Zhang et al., 2001) using FSL FAST 
(FMRIB, Oxford, UK).   
 
For diffusion MRI data using three orthogonal diffusion-sensitising gradients at a common b-
value, orientation-independent apparent diffusion coefficient (ADC) maps were obtained from  
𝐴𝐴𝐴𝐴𝐴𝐴 = − ln(𝑆𝑆1𝑆𝑆2𝑆𝑆3 𝑆𝑆03⁄ ) 3𝑏𝑏⁄  
where S1,2,3 are the signal intensities at the three orthogonal directions, S and S0 are the signal 
intensities with (b = 1000 s/mm2) and without (b = 0) diffusion weighting respectively and b is 
the b-value.  
Diffusion-weighted data with twenty independent diffusion-gradient directions (b=1000 mm2/s) 
and three b=0 images were processed using FSL DTIFIT from which the resulting mean-
diffusivity maps provided the ADC values. 
 
2.2. Image registration 
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Firstly, brain-extracted ADC images were non-linearly registered to the T2-weighted image 
space using FSL FNIRT via the diffusion S0 image and the T2 sum-over-echoes image. If T1-
weighted images were available, the T2-weighted image space was then linearly (six degrees 
of freedom) registered to the T1-weighted image space and then the latter space was linearly 
registered to the MNI frame at 1 mm3 isotropic resolution, using FSL FLIRT (Jenkinson and 
Smith, 2001). If T1-weighted images were not available, instead, the T2-weighted image space 
was linearly registered directly to the MNI frame at 1 mm3 isotropic resolution. All relevant 
images were then linearly registered to the MNI frame using the registration maps (or 
combinations of maps) generated by the previous stages. 
 
2.3. Lesion identification and mask creation 
A reference tissue mask was first created by the application of thresholds on T2 and ADC to 
reduce the contribution from CSF. These thresholds were typically 30 ms < T2 < 200 ms and 
0.1 µm2 ms-1 < ADC < 1.5 µm2 ms-1, respectively. A lesion tissue mask was then created in 
two stages. First, the thresholds (which could vary in individual cases) 30 ms < T2 < 200 ms, 
0.2 – 0.4 µm2 ms-1 < ADC < 0.55 – 0.60 µm2 ms-1 were applied and, secondly, the additional 
criterion that the ADC should be less than one half-width half-maximum from the median ADC 
of the reference tissue was applied. The lesion mask was then further refined by removing all 
but the largest contiguous cluster (or clusters, in cases with more than one lesion). 
Subsequently, the lesion mask was then removed from the reference tissue mask to create a 
non-lesion tissue mask. 
In order to examine GM and WM tissue only, further masks were created. GM and WM masks 
were obtained using FSL FAST with the T2-weighted, sum-over-echoes image as input, and 
specifying four tissue-types to be segmented. If available, T1-weighted images were used to 
generate a subcortical-structures mask via FSL FIRST. This mask was subtracted from the 
GM and WM masks to produce purely cortical GM and WM masks. These resulting masks 
were logically combined with the lesion and non-lesion tissue masks when investigating the 
tissue types separately. All masks were inspected visually. Note that when total lesions (‘all 
tissue’) were investigated, these masks were not employed.    
    
2.4 Algorithm for T2 change due to ischaemia: Spherical Reference method 
To calculate the change in T2 due to ischaemia for each voxel in the lesion, it is necessary to 
provide reference, T2R, values to which each voxel’s ischaemic T2 can be compared. That is, 
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an estimate is needed for the pre-ischaemic T2 within each voxel of the lesion. Reference T2 
values have previously been obtained (Siemonsen et al., 2009; Jokivarsi et al., 2010) from 
single contralateral voxels in the unaffected hemisphere, the so-called mirror reference 
method. However, such a method is prone to error due to the imperfect symmetry and inherent 
heterogeneity of the human brain, particularly in older patients and patients with 
cerebrovascular disease where T2 hyperintense WM lesions are common. To circumvent this 
issue, pre-ischaemic (reference) T2R values are calculated (via T2-weighted MR images) from 
a spherical volume of a given radius, centred on the contralateral voxel in the unaffected 
hemisphere.  
To achieve this, the algorithm adopts the premise that, in the hyperacute phase of ischaemia, 
the T2-weighted images are relatively insensitive to ischaemia and therefore the intensity 
values within each voxel of the lesion are sufficiently close to their pre-ischaemic values to be 
taken as estimates for their pre-ischaemic values (Welch et al., 1995; Moseley et al., 1990; 
McGarry et al., 2016). With this premise, the intensity 𝐼𝐼L of a lesion voxel can be used to 
condition the reference T2 for that voxel. 
Despite the relative insensitivity to ischaemia of the T2-weighted intensities, there may still be 
a dependency between the intensities and T2 values in normal brain tissue within any given 
region. Therefore, it is possible to obtain an estimate of pre-ischaemic T2 by using the intensity 
estimate of the pre-ischaemic intensity (i.e., the ischaemic intensity value 𝐼𝐼L) to calculate a 
type of conditional expectation of the T2 values within the reference sphere of a given lesion 
voxel. That is, an estimate of the pre-ischaemic T2 is obtained from the mean T2 of normal 
brain tissue within a reference sphere, conditioned by the intensity value 𝐼𝐼L of the ischaemic 
lesion voxel. 
To effect the conditioning, we employ a penalty function 𝐹𝐹L(𝐼𝐼) which weights the sum over the 
T2 values associated with voxels, indexed by 𝜌𝜌, in the reference sphere SL. Therefore, let the 
T2R be given by 
𝑇𝑇2
R = �𝑇𝑇2,𝜌𝜌𝐹𝐹L�𝐼𝐼𝜌𝜌�𝑁𝑁SL
𝜌𝜌=1
 
where 𝑁𝑁SL is the number of voxels in the reference sphere SL, and where the penalty function 
is normalised by ∑ 𝐹𝐹L�𝐼𝐼𝜌𝜌�𝑁𝑁SL𝜌𝜌=1 = 1. This may be equivalently expressed as 
𝑇𝑇2
R = 〈𝑇𝑇2𝐹𝐹L(𝐼𝐼)〉
〈𝐹𝐹L(𝐼𝐼)〉 = ∫d𝐼𝐼 𝐹𝐹L(𝐼𝐼)𝑃𝑃(𝐼𝐼)∫d𝑇𝑇2 𝑇𝑇2𝑃𝑃(𝑇𝑇2|𝐼𝐼)∫d𝐼𝐼 𝐹𝐹L(𝐼𝐼)𝑃𝑃(𝐼𝐼) = ∫d𝐼𝐼 𝐹𝐹L(𝐼𝐼)𝑃𝑃(𝐼𝐼)⟨𝑇𝑇2|𝐼𝐼⟩∫ d𝐼𝐼 𝐹𝐹L(𝐼𝐼)𝑃𝑃(𝐼𝐼)  
8 
 
where the integrals are over the values contained in the reference sphere, 𝑃𝑃(𝐼𝐼) is the 
probability density for the intensities, 𝑃𝑃(𝑇𝑇2|𝐼𝐼) is the conditional probability density for T2 given 
the intensity 𝐼𝐼, and ⟨𝑇𝑇2|𝐼𝐼⟩ is the mean T2 conditioned on 𝐼𝐼. 
In the limit that 𝐹𝐹L(𝐼𝐼) is constant, 𝑇𝑇2R is the unweighted mean T2 of all the voxels in the reference 
sphere. Conversely, in the limit that 𝐹𝐹L(𝐼𝐼) becomes a delta-function positioned at 𝐼𝐼 = 𝐼𝐼L, then 
𝑇𝑇2
R = �𝑇𝑇2�𝐼𝐼L�. However, in the present context, the use of a delta-function is impractical. 
Instead, a penalty function of finite width is employed, such that 
𝐹𝐹L�𝐼𝐼𝜌𝜌� = 𝐴𝐴Lexp�−�𝐼𝐼𝜌𝜌 − 𝐼𝐼L𝐼𝐼L �2 2𝜎𝜎2� � 
where 𝐴𝐴L is a normalisation constant which depends on the reference sphere SL associated 
with each lesion voxel. With this penalty function, T2R can be regarded as the mean T2 within 
the reference sphere, conditioned on a Gaussian neighbourhood of 𝐼𝐼L.  
Thus, for a given lesion voxel with intensity 𝐼𝐼L and T2-value 𝑇𝑇2L, from its reference sphere 
(centred on the contralateral voxel) we can obtain a reference T2-value 𝑇𝑇2R. We can therefore 
compute a measure of the estimated change in T2 due to ischaemia as a difference ∆𝑇𝑇2 =
𝑇𝑇2
L − 𝑇𝑇2R or a ratio 𝑟𝑟𝑇𝑇2 = 𝑇𝑇2L 𝑇𝑇2R⁄  for each lesion voxel, and use the median of these changes as 
an overall measure of the change in the ischaemic lesion. This method can also be used to 
estimate changes in other MRI parameters, such as the ADC value, provided that the 
distributions of this parameter and the intensity values are not statistically independent.    
In our implementation of this algorithm, the T2-weighted intensities were obtained from the 
sum-over-echoes image after bias-field correction. The reference sphere radius and penalty 
function width, σ, were obtained by optimisation on each patient data set by using the 
unaffected tissue in the hemisphere of the lesion (via the non-lesion tissue mask) to minimise 
the function 𝑓𝑓(𝛽𝛽) = MAD(∆𝑇𝑇2) +  𝛽𝛽|med(∆𝑇𝑇2)|, with 𝛽𝛽 = 5, where ∆𝑇𝑇2 is the calculated change 
in T2, med(∆𝑇𝑇2) is the median, and MAD(∆𝑇𝑇2) is the median absolute deviation. Median values 
for the reference sphere radii and penalty function width are provided in the Supplementary 
Material, Tables S1 and S2. 
A work-flow for image post-processing, the creation of various masks and use of these masks 
and images as inputs to the spherical reference algorithm, is shown in Figure 1. 
 
2.5 Mirror Reference method 
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We used the method essentially as proposed by Siemonsen et al. (Siemonsen et al., 2009) to 
determine a reference volume from the contralateral, non-ischaemic hemisphere, but without 
the need for manual adjustments. Since all image processing was performed in the MNI frame, 
the midline of the brain was consistently defined. Therefore, the lesion mask (see section 
above) could simply be reflected about the midline and then logically combined with the non-
lesion tissue mask to ensure that this contralateral (mirror reference) mask also contains valid 
tissue. To investigate GM and WM separately, the same operations were performed on these 
masks after logically combining with the GM and WM segmentation masks (see section 2.3). 
T2 statistics could then be easily compared between the lesion and the contralateral mask 
regions. 
 
2.6 Weighted regression analysis and statistics 
Weighted, least-squares, linear regressions were used to analyse the results obtained from 
the spherical and mirror reference methods, and the lesion ADC (median) values. The weights 
used for the regressions were the inverse-square errors of the medians (or combinations or 
medians). The errors for the medians were determined using the method of McKean and 
Schrader (McKean and Schrader, 1984; Price and Bonett, 2001) which derives the errors from 
the 95% confidence intervals of the distributions.  
The order of calculations for quantities of interest is slightly different when comparing the 
spherical and mirror reference methods. In the former method, differences or ratios are formed 
for each lesion voxel, producing a distribution from which measures can be obtained, namely, 
median values, MADs, and errors in the medians. We note here that the errors in the medians 
tend to be close to 1.48�𝜋𝜋 2𝑁𝑁⁄ MAD, where 𝑁𝑁 is the number of voxels in the lesion, which is 
the relationship expected when the distribution is Gaussian. In contrast, in the mirror reference 
method, quantities of interest are first calculated from the two regions; the lesion and 
contralateral reference. The medians are then combined as a difference or ratio. MADs and 
errors in medians, however, are propagated (in the usual manner for independent measures 
of error) for the difference or ratio of medians from the two regions. If the same order of 
calculations was followed for the spherical reference method, a second set of optimised 
penalty function parameters would have been required for this alternative procedure. 
Using a bootstrap method, it was found that of the order of at least 20 voxels were required to 
determine reasonably accurate estimates for the errors. Therefore, prior to performing the 
weighted regression, data were rejected if their region voxel count (whether connected or not) 
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was less than 20 (which corresponds to a volume of 20 mm3). For the mirror reference method, 
this test was applied to both the lesion and contralateral reference region.   
All weighted regressions were performed within MATLAB (Release 2016b, The MathWorks, 
Inc., Natick, MA, United States) using fitlm, which returns all regression parameters, 
confidence intervals, and significance tests. In order to compare regressions between GM and 
WM, the two data sets were concatenated and weighted regressions were performed with four 
parameters {𝑎𝑎, 𝑏𝑏, 𝑐𝑐,𝑑𝑑} such that the dependent variable 𝑦𝑦 was fitted to 𝑦𝑦 = 𝑎𝑎 + 𝑏𝑏𝑇𝑇 + 𝛾𝛾(𝑐𝑐 + 𝑑𝑑𝑇𝑇), 
where 𝑇𝑇 is the onset time, and 𝛾𝛾 = 1 for the GM data, and 𝛾𝛾 = 0 for the WM data. The fitted 
parameters 𝑐𝑐 and 𝑑𝑑 are the differences between the GM and WM intercepts and gradients, 
respectively, and thus can be subjected to a significance test for the null hypothesis, which 
fitlm provides.  
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3. RESULTS 
 
ADC and quantitative T2 images from four stroke patients with lesions involving different 
vascular territories are shown in Figure 2. Stroke lesions present as hypointense volumes in 
ADC images compared to the surrounding tissue. The stroke lesions’ boundaries are shown 
on the ADC images [Figure 2(a), (c), (e), and (g)] from which they were derived. Superimposed 
on the T2 images [Figure 2(b), (d), (f), and (h)] are the lesions segmented into GM and WM 
tissue types. 
Low ADC is a well-established MRI biomarker for ischaemia in the human brain (Welch et al., 
1995; Hjort et al., 2005; Burgess and Kidwell, 2011). The median ADC in the total lesions 
[Figure 3(a)], segmented GM [Figure 3(b)], and WM [Figure 3(c)] are shown as a function of 
onset time (see Table 3 for regression data). The ADC values are within the range reported 
for an ischaemic core in all volumes at the time of MR scans in the hyperacute phase of stroke, 
and the low ADC was the primary MRI criterion for assigning the lesion to ischaemic core (both 
in thrombolysed and not thrombolysed patients, Table S3). However, a low diffusivity lesion 
may be transient, and therefore it may not be a genuine core (Kranz and Eastwood, 2009). To 
address this issue, a subcohort of patients consented for a follow-up MRI 1 – 4 days after 
symptom onset. ADC lesion volumes for both hyperacute and follow-up MRI are shown in 
Figure 4. It is evident that on average the ADC lesions expanded from 1st to 2nd scan (Table 
1). However, a tendency towards volume decline was measured in 5 cases (31% of patients 
with follow-up scans), 4 of which were thrombolysed. Based on these data from the follow-up 
MRI, the ADC lesion in the hyperacute phase was regarded to represent the ischaemic core 
in 69% of all patients. 
 
Three quantities for quantitative T2 were examined for the total lesion (All Tissue in Figure 5), 
GM, and WM using the spherical reference method: med(∆𝑇𝑇2) [Figure 5(a) – (c)]; med(𝑟𝑟𝑇𝑇2) 
[Figure 5(d) – (f)]; and med(𝑟𝑟𝐼𝐼) [Figure 5(g) – (i)]. It can be seen that both med(∆𝑇𝑇2) and med(𝑟𝑟𝑇𝑇2) showed an increasing trend as a function of onset time, whereas the slope of med(𝑟𝑟𝐼𝐼) was not significantly different to zero. Table 4 summarizes the quantified parameters 
for the three MRI measures in the total lesion, GM, and WM. 
For the two measures of quantitative T2 change, GM and WM values correlated well with onset 
time, with gradients 1.4 – 2.0 ms h-1 for med(∆𝑇𝑇2), and 0.011 – 0.020 h-1 for med(𝑟𝑟𝑇𝑇2). Trends 
and statistics were similar for both of these measures. T2 changes as a function of stroke onset 
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time (median ± 95% confidence bounds) measured by the spherical reference method were 
1.94 ± 0.61, 1.50 ± 0.52 (p = 0.38 vs. the whole lesion) and 1.40 ± 0.54 (p = 0.18 vs the whole 
lesion) ms/hour in the whole, GM and WM lesions, respectively. For med(𝑟𝑟𝐼𝐼), the gradient was 
not statistically different to zero. For all quantities investigated with the spherical reference 
method, no significant differences in intercept or gradient were found between WM and GM. 
Figure 6 shows the T2 data obtained by the mirror reference method as follows: Figure 6(a) – 
(c), med�𝑇𝑇2L� − med�𝑇𝑇2R�, (the difference in median T2); Figure 6(d) – (f), med�𝑇𝑇2L� med�𝑇𝑇2R�� , 
(the ratio of median T2), and Figure 6(g) – (i), med�𝐼𝐼L� med�𝐼𝐼R�� , (the ratio of median T2-
weighted intensities). Positive slopes were evident for all volumes studied both for med�𝑇𝑇2L� −med�𝑇𝑇2R� and med�𝑇𝑇2L� med�𝑇𝑇2R�� . A tendency to a positive slope can be seen also for med�𝐼𝐼L� med�𝐼𝐼R�� . Quantitative indices for fitted regression lines are given in Table 4. 
For the two measures of quantitative T2 change that were used in the mirror reference method, 
GM and WM data correlated well with onset time, with gradients 1.6 – 3.2 ms h-1 for the 
difference of medians, and 0.016 – 0.028 h-1 for the ratio of medians. Trends and statistics 
were similar for both of these measures. For the intensity ratio, the gradient was statistically 
significant with values 0.008 – 0.013 h-1. For all quantities investigated with the mirror 
reference method, no significant differences in intercept or gradient were found between WM 
and GM. 
For analogous measures of quantitative T2 change between the spherical and mirror reference 
methods, the general trends were similar but the 95% confidence intervals, p-values, and 
RMSE tended to be smaller for the spherical reference method. For the intensity ratios, 
however, while the mirror reference method produced significant trends, the spherical 
reference method did not. The 95% confidence intervals and RMSE were also much smaller 
in the latter method.    
The patients recruited to the study were treated according to the NHS standard-of-care 
protocols, thus recombinant plasminogen activator was administered to eligible patients often 
prior to MRI. Linear regression characteristics for quantitative T2 data are also presented 
separately for thrombolysed and not thrombolysed patients (Table S4). It is evident that while 
∆T2 as determined by both methods showed highly significant correlation with onset time in 
thrombolysed patients, it was not different from zero in not thrombolysed cases (Table S4). 
Thrombolysis is not given to patients with mild and small strokes and we believe that non-
significant T2 change within the time frame up to 9 hours reflected mild disease states.  
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4. DISCUSSION 
 
We have developed a robust and user-unbiased procedure to quantify effects of stroke on T2 
relaxation time in the ADC-defined ischaemic core and have applied it to MRI data from a 
cohort of acute ischaemic stroke patients. The quantitative T2 changes measured by the 
spherical reference method, as a function of symptom onset time, agree well with those 
determined by the recently-introduced mirror reference method, which was the first method to 
objectively measure the effect of ischaemia on T2 relaxation time both in preclinical (Jokivarsi 
et al., 2010; McGarry et al., 2016) and clinical (Siemonsen et al., 2009) data sets. Our results 
show that increase in T2 relaxation time in quantitative terms is similar both in GM and WM to 
ischaemia with symptom onset time, an observation that may have potential value in 
interpreting MRI scans of stroke patients. 
 
While the reduction of ADC due to ischaemia has a large dynamic range, making it 
conspicuous by the bare eye, effects of ischaemia on T2 are small, requiring special 
referencing to non-ischaemic brain parenchyma to become detectable. The mirror reference 
method, wherein a homologous contralateral brain volume is chosen, utilises anatomical 
criteria for selection of a non-ischaemic reference region to determine the difference of 
average T2s. Using the mirror reference in rodent models, it was reported that T2 initially 
shortens both in the ischaemic core and parenchyma surrounding the core, the so-called 
ischaemia expansion tissue, followed by a time-dependent prolongation (Jokivarsi et al., 
2010). The temporal behaviour of T2 during the first hours has been attributed to cytotoxic 
edema (linked to anoxic depolarisation) followed by disintegration of intracellular 
macromolecules by proteases and lipases; the so-called cytotoxic edema dissociation model 
(Knight et al., 2015). The ∆T2 data as a function of symptom onset obtained by both the 
spherical and mirror reference methods here indicate that ∆T2 may be negative also in human 
brain in the early hours of stroke. Interestingly, Siemonsen and coworkers (Siemonsen et al., 
2009) reported only positive ∆T2 by the mirror reference approach in acute stroke patients 
scanned at 1.5T. Reasons for the discrepancy of ∆T2 data between the two studies remains 
unknown to us,, however, that the mirror reference method is critically dependent on accurate 
delineation of the reference volume (Norton et al., 2017), which may not be always obtainable 
in the human brain, as well as on the absence of any pathology in the reference that may 
affect T2. The latter factor becomes a serious concern in stroke patients, who often are aged 
with neurological co-morbidities that may influence MRI parameters.  
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The spherical reference method was designed to minimise the effects of potential confounds 
caused by brain asymmetry and tissue pathology in the reference volume, and also to make 
the reference selection user-unbiased. Reference volume delineation is based on T2-weighted 
signal intensity in the voxels of the ADC-defined lesion by seeking matching voxels in the 
contralateral hemisphere. Experimentally, T2-weighted signal shows no time-dependency in 
the ischaemic core of rat stroke for approximately the first 5 hours (Knight et al., 2015). In 
stroke patients, T2-weighted hyperintensity is commonly present only hours or days after 
symptom onset. Therefore, it is reasonable to use the T2-weighted signal in the ADC lesion 
during the first hours of stroke as a starting point in the search of a non-ischaemic reference. 
  
In the spherical reference method, there are two parameters associated with the penalty 
function that are optimised for each patient data set: the radius of the reference sphere and 
the penalty function width (Tables S1 and S2 for optimised parameter values). The 
optimisation procedure assumes that if the spherical reference method is used to calculate med(∆𝑇𝑇2) between two hemispheres of normal brain tissue the result should be approximately 
zero. However, there are at least two reasons why this assumption is not straightforward, and 
one or more of these could be the cause of the large range of optimised parameter values 
(Table S1). Firstly, normal tissue needs to be properly identified. In the current method, this is 
achieved by creating a non-lesion mask by removing the lesion mask from the brain mask 
(with CSF areas removed by applying an upper T2 limit). This simple method has obvious 
weaknesses: for example, in assuming that all the ischaemic lesions have been identified, or 
in assuming that the region affected by ischaemia is entirely within the ADC-defined region, 
or by assuming that there are no other pathologies present. In patients with white matter T2 
hyperintensities there is some suggestion that their presence in images might affect the 
optimised parameters (Table S2). Secondly, presumably due to imperfect bias-field correction 
(but perhaps also other issues or tissue characteristics), a zero-crossing for med(∆𝑇𝑇2) (as a 
function of reference sphere radius and penalty function width) is not always observed. For 
this reason, and also in the case where more than one zero-crossing is observed, the function MAD(∆𝑇𝑇2) +  5|med(∆𝑇𝑇2)| is minimised instead. A further point of concern with the current 
implementation of the optimisation is its lengthy execution time which, in addition to the other 
stages of the spherical reference method, would render the method of limited value in a clinical 
setting. Nonetheless, there is hitherto unexplored scope for improved efficiency, for example 
in reducing the number of normal-brain voxels required, or in employing smarter optimal-
parameter search algorithms.  
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∆T2 data as a function of symptom onset do not obviously differ when analysed by the two 
methods (Table 4). However, the spherical reference method shows smaller variation (95% 
confidence intervals on fitting parameters and regression lines) and RMSEs that are, 
throughout, substantially lower than by the mirror reference approach, indicating that the 
former is more robust in selecting non-ischaemic tissue that is similar to that affected by stroke. 
Median absolute deviations (displayed as ‘error’ bars in Figures 5 and 6) also tend to be 
smaller in the spherical reference method, as do the errors in the median values (used for the 
weighted regressions), which also imply that the voxel-selectivity at the centre of this method 
improves precision while maintaining accuracy. 
The order of (final) calculations for quantities of interest is different between the mirror and 
spherical reference methods. In the mirror reference method, median values are obtained from 
the lesion and mirror regions before combining these two values into a ratio or difference. The 
spherical reference method, however, is designed to place more importance on calculations 
at a voxel-wise level. In doing so, images of T2 change (such as the ∆T2 image in Figure 1) or 
histograms of T2 change in lesions or surrounding tissue (not shown) can be produced and 
analysed in terms of magnitude and spatial extent with regard to the ADC-defined lesion (or 
other images). This requires calculating the ratio or difference for each voxel in the lesion (or 
entire ipsilateral hemisphere) before any summarising median value is obtained. Thus, the 
order of final calculations is different for the proposed spherical reference method (ratio or 
difference, then median) to the mirror reference method (median values, then ratio or 
difference). It should be noted, nonetheless, that both methods can, in principle, be modified 
so that the final calculations have the same order. The mirror reference method can be 
changed so that each lesion voxel is combined with its contralateral voxel (assuming it exists) 
before taking the median of the combined values. The spherical reference method can be 
altered such that medians can be calculated from the lesion region and from the calculated 
reference 𝑇𝑇2R values before combining them. The disadvantage of the modified mirror 
reference method is that it becomes more sensitive to mismatches in tissue types between 
ipsilateral and contralateral voxels. The disadvantage of the modified spherical reference 
method is that the ability to produce images or histograms of T2 change is lost (note that it is 
likely that the optimised penalty function parameters will be different in the modified method).  
 
Comparing the measures of T2 change (Table 4) between GM and WM in the mirror reference 
method, it is observed that there is more variability in the figures for GM than for WM. 
16 
 
Unambiguously establishing which voxels are those primarily containing GM tissue can be 
problematic, particularly when analysing images which have undergone one or more spatial 
(registration) transformations. This, in addition to the known variability associated with the 
exact placement of the contralateral reference region, could be the main reasons for the larger 
uncertainty in the GM results. In this regard, it is interesting that the results of the spherical 
reference method do not appear to exhibit this tendency. This could be attributable to the 
reduced reliance of this method on the contralateral voxel positions and its voxel-matching 
feature. Nonetheless, both methods could potentially be improved by incorporating the partial-
volume information obtained from the segmentation procedure (FSL FAST).          
Our data show that time courses of ∆T2 in GM and WM are similar as a function of stroke 
symptom onset. At first glance, this is unexpected in the light of animal studies which have 
demonstrated different time dependencies in anoxic depolarisations (Kumura et al., 1999) and 
ADC (Pierpaoli et al., 1996) in the two brain tissue types. It should be realised, however, that 
there are several fundamental experimental differences between our clinical data and those 
from animal studies. Firstly, in the current study the earliest time points for MRI were obtained 
around 140 minutes after symptom onset, thus, no very early MRI data of stroke were available 
to us. Secondly, CBF thresholds for neurological symptoms and ischaemic energy failure 
(which triggers the drop in ADC) are different (Hossmann, 1994). Preclinical studies have 
shown that spontaneous electrical activity becomes disrupted at CBF levels that are 50 – 60% 
below the physiological level (Hossmann, 1994), whereas the ADC drop has a flow threshold 
that is approximately 80% below the normal flow (Busza et al., 1992). These CBF thresholds 
are time-dependent so that the ADC may decrease at a higher CBF level over a period of time 
than if the occlusion is instantaneous. Thus, the preclinical studies have reported 
electrophysiological and ADC data as a function of ischaemia, whereas in our clinical cohort 
the exact onset of ischaemia remains unknown, notwithstanding the ostensible symptom 
onset time.  
 
Limitations 
Prior to drawing conclusions regarding potential clinical implications of the current 
methodology and data in stroke medicine, several limitations should be considered. Firstly, 
the sample size is modest, comprising of a heterogeneous distribution of involved vascular 
territories. It is impossible to conclude, from the current data set, whether ∆T2 as a function of 
onset time is quantitatively uniform in different vascular territories. Secondly, the majority of 
patients in the current cohort (66%) were thrombolysed prior to MRI. Recanalization may or 
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may not normalise ADC (Li et al., 1999) or T2 (Kettunen et al., 2002) depending on the duration 
of ischaemia. Preclinical data demonstrate that if recanalization is successful, ADC recovers 
and T2 overshoots transiently (Kettunen et al., 2002), but if ADC remains low, T2 increases 
with time producing a prolonged T2 (Li et al., 1999). We have used the same ADC criterion for 
all patients to delineate the lesion, and furthermore, as the follow-up MRI data from 
thrombolysed patients indicate that the size of the ADC lesions increased in 11 out of 16 
cases, we assumed  that thrombolysis prior to first MRI had minimal or no effect on lesion T2. 
Thirdly, the three hospitals that were involved in this study used two types of MRI pulse 
sequences to quantify T2 in humans, which yield different absolute T2 values from brain 
parenchyma (this was partly the reason for considering ratio measures as well as difference 
measures of T2 change). The critical parameter used in determining the effects of stroke is 
∆T2. However, in the current data set it is impossible to separate ∆T2s in ADC lesions 
measured by either of the two MRI methods. 
 
In spite of the limitations above, the current data have potential clinical implications warranting 
further investigation. Firstly, quantitative ADC and T2 in combination may offer an objective 
way to evaluate effects of stroke on brain tissue, aiding in patient stratification. Recent clinical 
studies have used DWI/T2-FLAIR signals to evaluate lesion age (Thomalla et al., 2009; 
Thomalla et al., 2018).  The approach exploits a higher signal intensity arising due to the 
lengthened T2 and increased proton density as a proxy of lesion age. However, this signal 
increase may be counteracted by a T1 contribution, which increases with time after onset in 
the first hours in animal models (Kauppinen, 2014; McGarry et al., 2016), decreasing the 
FLAIR signal. “DWI/T2-FLAIR” mismatch as a proxy of lesion age is commonly determined 
visually, being classified by a binary value of whether or not a FLAIR and DWI lesion can both 
be seen (Thomalla et al., 2011). In a trial of 643 patients, it was shown that in the time range 
181 – 270 minutes, 53% of patients present a mismatch and 47% do not, and that patients 
with no mismatch, who would otherwise be ineligible for thrombolysis, greatly benefited from 
treatment (Thomalla et al., 2018). The spherical reference approach may provide even more 
quantitative information on the age of stroke lesions than visually-determined DWI/T2-FLAIR 
mismatch in an unambiguous manner, but the latter approach is pending a clinical trial. 
Secondly, stroke onset time-dependent T2 changes in GM and WM are comparable within the 
time window studied here. Therefore, T2 relaxation time serves as a proxy of tissue state 
independently of the brain tissue type in the ADC lesion volume. It should be noted that the 
situation may be different when T2-weighted intensities are used, due to potential contribution 
by T1 in scan acquisitions and the inherently distinct T1s in GM and WM.  
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5. CONCLUSIONS 
We have introduced a novel user-independent spherical reference method to quantify T2 
relaxation time changes in acute ischaemic stroke lesions with low ADC, both in GM and WM 
volumes. Using this technique, ∆T2 increases by 1.4 – 1.5 ms/h in both tissue types. We 
believe that quantitative MRI, exploiting T2 and ADC, will have potential clinical impact in the 
management of acute stroke patients, allowing an objective tissue-state evaluation of 
ischaemic parenchyma. The use of both quantitative T2 and DWI/FLAIR mismatch would 
represent a shift towards the use of tissue-based MRI indices to assess tissue state in stroke 
patients. 
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Figure 1. Flowchart showing the overall process of obtaining med(∆𝑇𝑇2) for the lesion, and a 
calculated ΔT2 image via the spherical reference method.  
The illustrated process begins with the four MNI-registered, brain-extracted, input images: 
ADC, T2-weighted (echo-summed), quantitative T2, and T1-weighted. Stage 1) Lesion 
Identification. ADC and T2 images are used to identify the ischaemic lesion and create three 
masks: the lesion mask; the non-lesion mask (normal tissue without CSF); the non-lesion, 
lesion-hemisphere mask (normal tissue in the hemisphere of the lesion). Stage 2) 
Segmentation. GM and WM segmentations are produced from the T2-weighted image, and a 
subcortical structure segmentation is produced from the T1-weighted image. Stage 3) Mask 
Combination. If GM and WM tissue is to be studied separately, the subcortical segmentation 
masks are logically removed from the GM and WM segmentation masks, and the resulting 
masks are logically combined with the three masks of stage (1) to produced cortical GM and 
WM versions (see centre grey square of the flowchart). Stage 4) Penalty Function 
Optimisation. The spherical reference algorithm (inputs are T2 and T2-weighted images) is 
executed many times in order optimise the penalty function radius and width. This is achieved 
by minimising MAD(∆𝑇𝑇2) +  5|med(∆𝑇𝑇2)|, where ∆𝑇𝑇2 is calculated between the voxels of the 
non-lesion, lesion-hemisphere mask and the contralateral hemisphere voxels of the non-lesion 
mask. Stage 5) Spherical Reference Algorithm. Using the optimised penalty function radius 
and width from stage (4), and via the T2 and T2-weighted images, med(∆𝑇𝑇2) is calculated for 
the lesion, using the lesion and non-lesion masks (or their segmented versions). A ∆𝑇𝑇2 image 
(shown in the top-right of the figure) can be produced by replacing the lesion mask with a 
lesion-hemisphere mask (not shown in the figure). 
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Figure 2. Examples of ADC images (a, c, e, g) with lesions demarcated, and quantitative T2 
images (b, d, f, h) with lesions segmented into WM (blue) and GM (red).  
Panels (a, b):  NIHSS at admission, 18; patient age, 45; stroke classification, TACS; onset 
time, 415 min. Panels (c, d): NIHSS at admission, 10; patient age, 57; stroke classification, 
LACS; onset time, 569 min. Panels (e, f): NIHSS at admission, 3; patient age, 86; stroke 
classification, POCS; onset time, 408 min. Panels (g, h): NIHSS at admission, 5; patient age, 
80; stroke classification, POCS; onset time, 338 min. 
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Figure 3. Lesion ADC values. The solid black line is the linear regression with observational 
95% confidence intervals displayed by dashed black lines. The displayed error bars are the 
median absolute deviations. Regression results are given in Table 3.  
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Figure 4. ADC lesion volumes (in mm3) for the subset of patients with both a hyperacute scan 
(scan 1) and a follow-up scan (scan 2). 
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Figure 5. Spherical Reference method regressions for All Tissue, GM and WM lesions.  
The solid black line is the linear regression with observational 95% confidence intervals 
displayed by dashed black lines. The ‘error’ bars displayed in the plots are the median absolute 
deviations (MADs) and represent the spread of values within the lesion or, alternatively, can 
be regarded as representing the tissue-state heterogeneity of the lesion. Regression results 
are given in Table 4. 
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Figure 6. Mirror Reference method regressions for All Tissue, GM and WM lesions.  
The solid black line is the linear regression with observational 95% confidence intervals 
displayed by dashed black lines. The ‘error’ bars depicted in the plots are the propagated  
MADs (see Methods section) from the lesion and contralateral regions. Regression results are 
given in Table 4. 
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Table 1. Patient data presented for the whole cohort in the hyperacute phase (all hyperacute 
patients) and for the subset who also received a follow-up MRI scan. Ranges presented in 
the table in parentheses are in the format: median (minimum – maximum). 
Variable All Hyperacute Data Subset with Both 
Hyperacute and Follow-up 
Scans 
Patients, n (% overall cohort) 38 (100%) 16 (42.1%) 
Female, n (% group) 12 (31.6%) 5 (31.3%) 
Scan site, n (% group)   
  Bristol 19 (50.0%) 3 (18.8%) 
  Glasgow 15 (39.5%) 11 (68.8%) 
  Oxford 4 (10.5%) 2 (12.5%) 
Age 68 (31 – 87) 68 (45 – 87) 
Received r-tPA before MRI, n(% group) 25 (65.8%) 12 (75.0%) 
Median time from rtPA to MRI (h:min) 3:17 (0:29 – 7:18) 4:12 (0:38 – 7:18) 
Median time from onset to MRI (h:min) 5:38 (2:25 – 9:29) 6:52 (3:04 – 9:29) 
Days from onset to follow-up MRI - 1 (1 – 4) 
NIHSS† on admission 6 (1 – 28) 8.5 (1 – 21) 
Stroke subtype‡, n (% group)   
  Lacunar (LACS)  15 (39.5%) 6 (37.5%) 
  Partial Anterior Circulation (PACS)  11 (28.9%) 5 (31.3%) 
  Posterior Circulation (POCS) 4 (10.5%) 1 (6.3%) 
  Total Anterior Circulation (TACS) 8 (21.1%) 4 (25.0%) 
Left hemisphere stroke 15 (39.5%) 6 (37.5%) 
ADC lesion volume [cm3]   
  Hyperacute 1.95 (0.04 – 97.51) 3.57 (0.12 – 20.50) 
  Follow-up - 4.01 (0 – 44.53) 
†Scores on the National Institutes of Health Stroke Scale (NIHSS) range 0 – 42, with higher 
scores indicating greater severity. ‡Strokes classified according to the Oxford Stroke 
Classification Scale (Bamford et al., 1991)  
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Table 2. MRI sequence details and acquisition parameters. 
Site 
T2 
Sequence 
TR 
[ms] TE [ms] 
Resolution 
[mm3] 
  
Bristol GRASE 3000 20, 40, 60, 80, 100 0.6×0.6×2.3   
Glasgow TSE 12500 9.5, 66, 123 1.7×1.7×2.0   
Oxford FSE 12000 7.7, 77, 177 1.8×1.7×2.0   
Site 
T1 
Sequence 
TR 
[ms] TE [ms] 
Resolution 
[mm3] TI [ms] Flip Angle 
Bristol 3D FFE 6.84 3.18 1.0×1.0×1.1 N/A 8° 
Glasgow MP-RAGE 2200 2.28 0.9×0.9×0.9 900 9° 
Oxford MP-RAGE 1800 4.55 1.5×1.5×1.0 900 8o 
Site 
Diffusion 
Sequence 
TR 
[ms] TE [ms] 
Resolution 
[mm3] 
b-value [s/mm2] 
(Multiplicity) 
Independent 
Gradient 
Directions 
Bristol SE-EPI 3009 60.5 1.2×1.2×4.4 0 (1), 1000 (3) 3 
Glasgow SE-EPI 8000 90 0.9×0.9×2.0 0 (3), 1000 (20) 20 
Oxford SE-EPI 5300 91 1.8×1.8×5.0 0 (1), 1000 (1) 3 
 
  
30 
 
Table 3. Weighted linear regression results for the ADC within the lesion [see Figure 3(a) – 
(c)]. r2 is the square of the correlation coefficient, RMSE is the root-mean-square error of the 
residuals, p is the two-tailed p-value, n is the number of data points. Errors in the intercept and 
gradient are the 95% confidence intervals. 
Tissue Intercept [mm2/s] Gradient [mm2/s/h] r2 RMSE p n 
All 4.96×10-4 ± 0.44×10-4  -1.8×10-6 ± 7.7×10-6 0.0065 4.69×10-5 0.629 38 
GM 4.96×10-4 ± 0.54×10-4 -4.2×10-6 ± 9.1×10-6 0.0369 3.68×10-5 0.347 26 
WM 5.00×10-4 ± 0.46×10-4 0.1×10-6 ± 8.3×10-6 2.1×10-5 5.27×10-5 0.979 35 
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Table 4. Weighted linear regression results for spherical reference [Figure 5(a) – (i)] and mirror 
reference [Figure 6(a) – (i)] approaches. The data are displayed in the same order as the 
Figure panels. *Units for median ∆𝑇𝑇2 (spherical reference) and the difference of median 𝑇𝑇2 are 
ms. Ratios are dimensionless. Units for the gradients are quoted in the appropriate units per 
hour. r2 is the square of the correlation coefficient, RMSE is the root-mean-square error of the 
residuals, p is the two-tailed p-value (testing the gradient against the null hypothesis), pGM-WM 
is the two-tailed p-value testing the hypothesis that the gradients for GM and WM are 
identical), n is the number of data points. Errors in the intercept and gradient are the 95% 
confidence intervals. 
Method Measure Tissue Intercept* Gradient* r2 RMSE p pGM-WM n 
Sp
he
ric
al
 R
ef
er
en
ce
 
Median 
∆𝑇𝑇2 
All -4.8 ± 3.3 1.94 ± 0.61 0.534 2.96 1.91×10-7  38 
GM -2.8 ± 2.6 1.50 ± 0.52 0.583 1.68 3.62×10-6 
0.810 
27 
WM -1.2 ± 2.8 1.40 ± 0.54 0.460 2.21 5.71×10-6 35 
Median 
𝑇𝑇2 ratio 
All 0.955 ± 0.032 0.0202 ± 0.0058 0.583 0.0296 2.43×10-8  38 
GM 0.992 ± 0.024 0.0112 ± 0.0045 0.514 0.0165 2.60×10-5 
0.438 
27 
WM 1.001 ± 0.029 0.0142 ± 0.0056 0.445 0.0241 1.07×10-5 35 
Median 
intensity 
ratio 
All 0.9991 ± 0.0011 2.2×10-4 ± 2.2×10-4 0.103 8.08×10-4 0.049  38 
GM 1.0008 ± 0.0007 -9.2×10-5 ± 9.4×10-5 0.139 3.16×10-4 0.055 
0.0689 
27 
WM 0.9999 ± 0.0005 0.5×10-4 ± 1.2×10-4 0.023 5.32×10-4 0.383 35 
M
irr
or
 R
ef
er
en
ce
 
Difference 
of 
median 𝑇𝑇2 
All -3.4 ± 4.2 2.30 ± 0.83 0.465 3.73 2.42×10-6  38 
GM -10.1 ± 6.1 3.2 ± 1.1 0.592 4.21 4.30×10-6 
0.0311 
26 
WM -0.6 ± 2.9 1.60 ± 0.57 0.498 2.36 2.18×10-6 35 
Ratio of 
median 𝑇𝑇2 
All 0.986 ± 0.041 0.0214 ± 0.0079 0.453 0.0403 3.65×10-6  38 
GM 0.917 ± 0.073 0.028 ± 0.013 0.449 0.0531 1.80×10-4 
0.102 
26 
WM 1.013 ± 0.033 0.0158 ± 0.0062 0.447 0.0284 1.13×10-5 35 
Ratio of 
median 
intensities 
All 0.964 ± 0.037 0.0125 ± 0.0076 0.238 0.0395 1.89×10-3  38 
GM 0.959 ± 0.031 0.0104 ± 0.0061 0.344 0.0216 1.65×10-3 
0.612 
26 
WM 0.976 ± 0.022 0.0080 ± 0.0046 0.279 0.0196 1.12×10-3 35 
 
 
 
